For research use only. Not for therapeutic Use.
PSB-18484(Cat No.:I035140)is a selective small molecule inhibitor of the enzyme soluble epoxide hydrolase (sEH). By inhibiting sEH, PSB-18484 enhances the activity of epoxyeicosatrienoic acids (EETs), which play a role in regulating blood pressure, inflammation, and vascular function. It has potential therapeutic applications in conditions like hypertension, cardiovascular diseases, and inflammation-related disorders. Preclinical studies suggest that PSB-18484 may help improve endothelial function and reduce vascular inflammation. However, further clinical research is needed to determine its efficacy and safety in humans before widespread medical use.
Catalog Number | I035140 |
Synonyms | PSB-18484; PSB 18484; PSB18484. |
Molecular Formula | C12H9FINO4 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | 3-(2-carboxyethyl)-4-fluoro-6-iodo-1H-indole-2-carboxylic acid |
InChI | InChI=1S/C12H9FINO4/c13-7-3-5(14)4-8-10(7)6(1-2-9(16)17)11(15-8)12(18)19/h3-4,15H,1-2H2,(H,16,17)(H,18,19) |
InChIKey | DDCPVTXQTABQGM-UHFFFAOYSA-N |
SMILES | C1=C(C=C(C2=C1NC(=C2CCC(=O)O)C(=O)O)F)I |